Clinical Trial: A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07700238) titled 'A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)' on July 07.

Brief Summary: This Phase 3 study is designed to evaluate the efficacy and safety of romiplostim in combination with predniso(lo)ne compared with predniso(lo)ne alone in adults with previously untreated Primary Immune Thrombocytopenia (ITP).

Study Start Date: July 20

Study Type: INTERVENTIONAL

Condition: Primary Immune Thrombocytopenia

Intervention: DRUG: Romiplostim

Administered subcutaneously.

DRUG: Predniso(lo)ne

Administered orally.

Recruitment Status: NOT_YET_...